Menu

Budenofalk治疗哮喘疗效怎么样?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

How effective is it in treating asthma? Clinical trials were conducted to observe and evaluate the clinical effect of montelukast sodium combined with Budenofalk in the treatment of bronchial asthma. Methods: 65 patients with bronchial asthma admitted to our hospital from July 2014 to July 2015 were selected as clinical subjects and randomly divided into a control group and an observation group. The control group was treated with budesonide, and the observation group was treated with montelukast sodium combined with Budenofalk. The efficacy of the two groups was observed and compared.

The results showed that the total effective rate of treatment in the observation group was higher than that in the control group. After statistical analysis, there was a significant difference with P<0.05. Conclusion: Clinical patients with bronchial asthma have achieved significant results and are highly safe after being treated with montelukast sodium combined with Budenofalk.

Chemical name: 16a, 17a-22R, S-propylmethylenedioxy-pregnant-1,4-diene-11b, 21-dihydroxy-3,20-dione (16a(R), Budenofalk is a new type of inhaled glucocorticoid Hormone asthma treatment drugs belong to the adrenocortical hormone drugs. Budenofalk is a non-halogenated glucocorticoid that has a strong local anti-inflammatory effect and can inhibit early bronchospasm and late allergic reactions. Budenofalk K is one of the important drugs for the treatment of allergic asthma. It has a highly effective local anti-inflammatory effect among similar drugs. It is significantly more effective than beclomethasone propionate and other glucocorticoids. It has a long acting time and has no systemic adrenocortical hormone effect. It is more suitable for local use. , is a first-line drug for the treatment of asthma by aerosol inhalation and the treatment of allergic reactions by spraying into the nasal cavity. Budenofalk has two configurations: R and S. The anti-inflammatory effect of the R configuration is 2 to 3 times higher than that of the S configuration, and its other pharmacokinetic properties are also better.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。